3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Atherosclerosis
1
Advanced Renal Cell Carcinoma (RCC)
1
Interventions
Nivolumab
6
pembrolizumab
3
Specimen Handling
3
Ipilimumab
3
relatlimab
2
cemiplimab
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
vedolizumab
1
trametinib
1
toripalimab
1
sulforaphane
1
gadopiclenol
1
famitinib
1
anlotinib
1
X-Rays
1
Watchful Waiting
1
Ultraviolet Therapy
1
Toll-Like Receptor 1
1
Therapeutics
1
Temozolomide
1
Technetium
1
Standard of Care
1
Sentinel Lymph Node Biopsy
1
SHR-1701
1
Rehabilitation
1
Phototherapy
1
Photopheresis
1
Pemetrexed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Melanoma
×
Atorvastatin
×
Clear all
NCT06785974
2025-01-22
SPIRAL
Erasmus Medical Center
Phase 4
Not yet recruiting
140 enrolled